On the other hand, anakinra was marginally effective in two female patients with established diagnoses of juvenile idiopathic arthritis, aged approximately 6 and 12 years, who were partially responsive to anti-TNF treatment. The gene discussed is TNF; the disease is juvenile idiopathic arthritis.